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Abstract
Background: Adolescent depression is a global mental health concern. Identification and effective prevention in an
early stage are necessary. The present randomized, controlled trial aimed to examine the effectiveness of Cognitive
Behavioral Therapy (CBT)-based depression prevention in adolescents with elevated depressive symptoms. This
prevention approach is implemented in school communities, which allows to examine effects under real-life
circumstances.
Methods: A total of 5222 adolescents were screened for elevated depressive symptoms in the second grade of
secondary schools; 130 adolescents aged between 12 and 16 years old (M = 13.59; SD = 0.68; 63.8% girls) were
randomly assigned to the experimental (OVK 2.0) or control condition (psycho-education). Self- and parent-reported
depressive symptoms were assessed at pretest and post intervention, as well as 6- and 12-months follow-up.
Clinical assessment of depression was assessed at pretest and 6-months follow-up.
Results: Intent-to-treat analyses revealed that the decrease in adolescent-rated depressive symptoms was
significantly larger in the intervention condition than in the control condition. There was no significant difference in
decrease of parent-rated depressive symptoms between both conditions.
Conclusions: Based on the findings, we recommend the implementation of screening and prevention in schools,
according the basics of this study design. Since this is a new step forward, we discuss the clinical impact and
challenges, as well possibilities for future research.
Trial registration: The study is registered in the Dutch Trial Register for RCT’s (NTR5725). Date registered: 11 March
2016.
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Background
Depression is a common disorder that affects millions of
people worldwide and is nowadays the leading cause of
disease burden, according to the World Health
Organization [1]. The onset of a depression often starts
in adolescence with rates that increase substantially be-
tween 13 and 18 years of age [2]. In the Netherlands, the
life time prevalence of a depressive disorder in this age
group is 15.5%, and 8.8% experienced a depressive dis-
order in the past 12 months [3]. The early onset of de-
pression, but also the presence of subclinical depression,
affects the academic and interpersonal functioning and
is associated with other psychopathologies, such as sub-
stance use, anxiety, and suicidality [4–7]. On the longer
term, depression in adolescence is often linked to recur-
rent and chronic depressive episodes in adulthood [8, 9].
Consequently, prevention programs for adolescents re-
ceive growing attention. Several prevention programs
worldwide were developed and examined on three levels:
(1) universal prevention, which is aimed at all individ-
uals; (2) selective prevention, which is aimed at individ-
uals at risk for depression; and (3) indicated prevention,
which is aimed at individuals with elevated depressive
symptoms [10]. Overall, meta-analyses have established
that depression prevention programs among adolescents
are more effective in reducing depressive symptoms than
usual care, waiting lists, or monitoring conditions with
the largest effect sizes for selective and indicated preven-
tion [10–13]. Although the effects are small to moderate
and outcomes are heterogeneous, it seems important to
continue with implementing and evaluating selective and
indicated prevention programs for depression [11].
Studies so far have provided useful information about
the effectiveness of specific elements that are covered in
depression prevention programs. For example, we know
that programs based on cognitive behavioral therapy and
interpersonal treatment (IPT) have the largest effect
sizes. Also, the duration of prevention programs can
affect the magnitude of treatment effects, with shorter
programs being more effective in reducing depressive
symptoms [10, 13–15]. Moreover, factors concerning the
delivery of prevention programs can improve the effects.
For example, effect sizes for school-based programs are
larger when delivered by a psychologist than school staff
[13, 16, 17]. Despite this knowledge, there is limited evi-
dence for the effectiveness of indicated depression pre-
vention programs that are actually implemented in
schools [11, 18].
Implementation of prevention programs seems to suf-
fer from the large gap that exists between research and
practice. Schools, for example, are often utilized for the
examination of prevention programs, as this provides an
easy way to reach adolescents and relieves most practical
barriers, such as location, costs, and time [11, 19].
However, the implementation of prevention programs—
in the context of research—is generally more ad hoc
than the actual implementation of evidence-based pro-
grams in schools with the purpose of preventing symp-
toms of psychopathology. The process of transferring
evidence into practice asks for an adequate infrastruc-
ture and engaging schools and individuals in the process
of implementation takes a lot of effort [20]. Additionally,
there are factors that may complicate implementation,
such as poor financing, a lack of public awareness, and a
non-supportive political atmosphere [21]. Therefore, ra-
ther than focusing on if, we should focus on how we can
provide prevention programs in a sustainable manner.
To meet this ambition, we examined the effectiveness
of depression prevention for high-risk adolescents when
fully implemented in school communities. Prior to the
study, an intensive collaboration was started between all
the schools in a rural area in the south of the
Netherlands, public health services, the caregivers within
the schools, and mental healthcare services that were
connected to the schools. We named this collaboration
on depression prevention the STORM-project, which
stands for Strong Teens and Resilient Minds. The fol-
lowing preventive interventions were included: (1) early
screening on depressive symptoms and suicidal ideation;
(2) detected suicidality, followed by clinical referral; and
(3) an indicated prevention program of eight sessions
based on CBT for adolescents with elevated depressive
symptoms. All participating organizations had a part in
the prevention process, with the public health service re-
sponsible for screening and referral; with the school’s li-
censed psychologists, together with caregivers from
mental healthcare organizations, delivering the preven-
tion program; and with the specialized mental healthcare
institutes providing care for adolescents with high sui-
cidal risk and supporting the process by sharing expert-
ise and providing training.
Besides the benefits of collaboration on the communi-
cating level, the continuity of care, and the expected re-
duction in overall mental healthcare costs, collaboration
in the process of screening, identification, and preven-
tion allows to identify and reduce depressive symptoms
before they become severe. According to the clinical
guidelines for the treatment of depression, collaboration
is essential to ensure timely and effective access to help,
and prevention programs should also benefit from col-
laboration [22–24]. Several recent meta-analyses made
clear that collaborative care leads to better patient out-
comes, reductions in health costs, and better patient and
provider satisfaction [25, 26]. Although a number of
studies proved the effect or effectiveness of CBT depres-
sion prevention programs by involving school staff or
community providers into the delivery of the program
[13, 27, 28], this is one of the first study that proved the
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effectiveness of indicated depression prevention with the
process of screening and prevention implemented in the
school community—based on a strong collaboration
with schools and caregivers [10, 11, 15, 18].
Present study
The purpose of the current study was to evaluate the ef-
fectiveness of a CBT depression prevention program—
Op Volle Kracht 2.0 (OVK 2.0, which translates to At
Full Force)—as implemented in school communities in
the prevention of depression for adolescents with ele-
vated depressive symptoms. A randomized controlled
trial (RCT) was conducted, in which we screened adoles-
cents on the presence of depressive symptoms and allo-
cated participated adolescents with elevated depressive
symptoms to the intervention and an active control con-
dition, in which participants received psycho-education.
The implementation of an infrastructure based on col-
laboration within school communities allowed us to
evaluate OVK 2.0 under real world circumstances.
From a baseline to 12-month follow-up, as reported by
adolescents and parents, we hypothesized that OVK 2.0
would lead to greater reduction in depressive symptoms,
compared to psycho-education. Furthermore, we ex-
pected that adolescents who received OVK 2.0 would
have a lower chance of depression onset after the
intervention.
Methods
The medical ethics committee CMO Region Arnhem-
Nijmegen of the Netherlands approved this study
(NL55328.091.15). The study is registered in the
Dutch Trial Register for RCT’s (NTR5725). The study
design will be reported in accordance with the CON-
SORT 2010 statement for reporting parallel group
randomized trials [29].
Procedure
A total of 5222 adolescents in the second year of 13 sec-
ondary schools, from vocational training up to pre-
university level, were screened on depressive symptoms
during two consecutive school years (October–March
2016/2017 and October–March 2017/2018) with the
Children’s Depression Inventory 2 (CDI-2) [30, 31]. The
screening was performed by the public health service (in
Dutch: GGD) and was part of a larger routine health
survey.
Inclusion criteria were elevated depressive symptoms
according to the screening (score ≥ 14 CDI-2) [30], ages
between 11 and 15 years old, and sufficient knowledge of
the Dutch language to participate. Exclusion criteria
were the absence of parental permission, already under-
going CBT for mood problems, or the presence of high
suicidality. Sixteen adolescents (0.3%) presented high
suicidal ideation, and they were referred to mental
healthcare organizations. All 457 (8.7%) adolescents who
scored above the cutoff of 14, along with their parents,
received information regarding the study. Next, adoles-
cents and parents were contacted by the research team.
After receiving informed assent from adolescents and
parents, participants were randomly allocated to the ex-
perimental or control condition, stratified on school
level. The randomization was carried out within schools
by an independent researcher using a computer-
generated randomization procedure. Adolescents and
parents completed online surveys at the baseline (T1),
after the intervention (T2), at 6-month follow-up (T3),
and at the 12-month follow-up (T4). In addition, adoles-
cents received a semi-structured clinical interview at the
baseline and 6-month follow-up to determine the pres-
ence of clinical depression. Participants were informed
of group allocation before the baseline measurement
(T1). Adolescents received gift vouchers as a reward for
filling in the questionnaires. More information about the
procedure and participant flow is provided in Fig. 1.
When participants during the study appeared to be at
high risk for suicidality (as appeared from the question-
naires) or at risk for a severe clinical depression (as mea-
sured by the interview at the 6-month follow-up), they
were seen by a professional of the public health service,
parents were informed, and eventually, information
about referrals were provided.
Sample size and power
The intended main analysis strategy, as described in the
study protocol [32], was a repeated measures ANOVA. To
find a significant difference in depressive symptoms be-
tween conditions, a sample size of 78 was needed (type I
error probability of 0.05, power = 0.80, and medium effect
size of f = 0.25). Including the effect of clustering data
(group effect because the intervention was given in small
groups), and an ICC of 0.07 in a comparative study [33]),
the variance inflation factor became 1.49. The sample size
had to be raised to 117 participants. Including the possible
drop out of participants, the intended sample size was
160. The choice for an effect size of f = 0.25 was based on
comparable studies [11, 33]. Regarding the analysis
method, latent growth curve modeling (LGCM) [34] was
planned as an additional strategy but was chosen as the
main strategy above repeated measures ANOVA, as this is
a more flexible approach and directed to individual
change over time. Given that repeated measures ANOVA
is comparable with LGCM, we assumed that the power of
the two techniques is about the same.
Participants
Out of the 5222 adolescents, 469 (62.7% girls) had ele-
vated depressive symptoms and were approached for
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participation in the study. Finally, 130 adolescents
(63.8% girls) with elevated depressive symptoms partici-
pated. The participants were aged between 11 and 15
years (M = 13.59; SD = 0.68). Educational levels were as
follows: vocational training (45.4%), vocational or high
school training (5.4%), high school training (17.7%), high
school or pre-university training (2.3%), and pre-
university training (19.2%). Most participants were of
Dutch origin (85.4%). Of the participants, 59.2% lived
with their biological parents, and the other participants
had divorced parents or a different family situation and
lived, for example, with their foster parents.
Interventions
OVK 2.0
The Penn Resiliency Program (PRP) (30), which proved
to be effective as a school-based universal prevention in
the United States (US), was adapted to the Dutch culture
and called OVK [35, 36]. The goal of this CBT-based
prevention program is to teach adolescents to identify
Fig. 1 Flow diagram of participants
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thoughts and emotions, as well as how activating events,
thoughts, emotions and behaviors are related. In contrast
to PRP, the OVK program did not prevent or decrease
depressive symptoms on an universal and selected level
[37, 38], but it did prove to be effective among adoles-
cent girls when used as indicated prevention in a short-
ened protocol (i.e., 8 lessons instead of the original 16)
[33].
OVK 2.0 is a modified and more up-to-date version of
the original OVK program. Equal to the study of Wijn-
hoven and colleagues [33], it consists of eight weekly, 1-
hour lessons in groups of three to eight adolescents.
These eight lessons are based on CBT techniques.
Homework in OVK 2.0 includes mood monitoring and
energizing assignments that are based on positive psych-
ology. Moreover, multi-media sources are included. Be-
fore the start of the program, there was an individual
intake with the adolescent and the trainers and an infor-
mation meeting for the adolescents and their parents.
Three months after the program, the trainers organized
a booster session for the adolescents and their parents.
More details about the content of the program are de-
scribed in a protocol paper [32].
The program was delivered by school psychologists
who were also staff members at school, together with a
co-trainer of the collaborated mental healthcare organi-
zations. They all received a 3-day training program, cov-
ering training in CBT skills, theoretical principles, and
the use of the prevention protocol. We measured treat-
ment fidelity through a self-report questionnaire, asses-
sing which exercises were actually given and that
trainers had to fill in after each lesson. The treatment fi-
delity was 84.7% (range from 74.6 to 94.7%).
Psycho-education
The participants in the psycho-education condition re-
ceived a brochure with information about depressive
symptoms. Also, participants received two e-mails with
useful tips to boost their mood and decrease depressive
symptoms. For example, they were encouraged to do
more physical exercises and to find a sport they might
like.
Measures
Depressive symptoms were measured with the CDI-2
[30, 31]. The CDI-2 is a self-report questionnaire
comprising 28 items, each consisting of three state-
ments rated in severity from 0 to 2 (e.g., “I don’t feel
alone” = 0, “I often feel alone” = 1, “I always feel
alone” = 2). The CDI-2 was used for screening pur-
poses, in accordance with the Dutch clinical guide-
lines for depression among youth [24]. The CDI-2
has good psychometric qualities [39]. In this study,
Cronbach’s alpha ranged between 0.78 and 0.89.
Depressive symptoms according to parents were mea-
sured with the Dutch translation of the parent version of
the CDI-2 [30, 31]. This questionnaire comprised 17
items that are measured on a 4-point scale from 0 (not
at all) to 3 (almost always), and parents had to rate the
extent to which the items were in accordance with their
child’s thoughts, feelings, and behaviors (e.g., “My child
seems lonely”). The psychometric qualities of the parent
version of the CDI-2 were good [39]. In this study,
Cronbach’s alpha ranged between 0.78 and 0.85.
The presence of a clinical depression was measured by
the Dutch version of the Anxiety Disorder Interview
Schedule for Children (ADIS-C) [40, 41] during a clin-
ical interview. This is a semi-structured diagnostic inter-
view of the symptomatology, course, and severity of
anxiety, mood disorders, and externalizing disorders in 7
to 17-year-old children, according to the DSM IV diag-
nostic criteria. In the study, we included a separate sec-
tion relating to mood disorders, which includes the
diagnostic criteria for dysthymic disorder and major de-
pressive disorder. The interview took about 10 to 20
min, and it was administered by a qualified psychologist
or by a trained master student under the supervision of
a qualified psychologist. Participants had to respond
“yes,” “no,” or “different” to standardized questions. The
purpose of this interview was to investigate whether chil-
dren met the criteria for a dysthymic disorder or major
depression disorder. Interrater reliability and test-retest
reliability of the ADIS-C were found to be good [42].
Suicidality (i.e., the presence of suicidal ideation) was
measured with item 8 of CDI-2 on a three point scale
(0 = “I don’t think about ending my life,” 1 = “I think
about ending my life, but I would never do it,” and 2 = “I
want to end my life”). When adolescents reported a
score of 2 on this item, during the screening or follow-
ups, they were approached for an assessment by profes-
sionals of the public health service. These professionals
were trained in the assessment of suicide risk by the pro-
ject staff. In this assessment, the presence and severity of
suicidality was checked, parents were informed, and clin-
ical referrals were provided when necessary. During the
screening, 54 adolescents scored 2 on the CDI-2 and
were subsequently interviewed. Of these adolescents, 31
(57.4%) made a mistake, were joking, or misinterpreted
this item; 7 (13.0%) adolescents were at low risk for sui-
cidality and were approached for participation; 3 (5.5%)
adolescents were at high risk for suicidality and needed
to be referred to mental healthcare; 10 (18.5%) adoles-
cents were at high risk for suicidality and received
already mental healthcare and, in some cases, upscaling
of care was necessary and this was discussed with the in-
volved care provider; and 3 (5.5%) adolescents were at
such high risk for suicidality that immediate help was
necessary. When adolescents reported suicidality on
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follow-up measurements, they were contacted by the re-
search team and invited for an assessment by the public
health service. These participants were not excluded
from the study.
Demographical variables were gender, educational
level (i.e., vocational training or higher education), ethni-
city (i.e., whether born in the Netherlands), and family




We conducted logistic regression analyses to analyze attri-
tion at screening (T0; n = 465) trough baseline (T1; n =
130). Enrollment was used as the dependent variable, and
depressive symptoms levels at screening and gender were
used as predictors. The results indicated no differences for
gender (OR = 0.88; p = 0.546) or depressive symptoms
level (OR = 0.98; p = 0.455). Attrition was also analyzed for
adolescents who were labeled as drop-outs because they
did not fill in the questionnaires at T2, T3, and T4 or
withdrew early in the study. No significant effects were
found for the following: condition (OR = 0.67; p = 0.671),
gender (OR = 0.43; p = 0.378), school level (OR = 4.50;
p = 0.193), and ethnicity (OR = 1.68; p = 0.682).
During the study, we became aware of suicide at-
tempts by two participants. One was reported by the
mother in the parent questionnaire, and the other was
informed by one of the collaboration partners. Both were
girls, one in the experimental condition and one in the
control condition. We reported these suicide attempts as
serious adverse events.
Analyses
First, descriptive statistics and z-tests were used to de-
scribe and to analyze differences in depressive symptoms
at all time-points for adolescents and their parents, with
help of the statistical package, Mplus [34].
The data were analyzed according to the intent-to-
treat principle. To examine change in depressive symp-
toms over time, we used LGCM with Mplus [34]. Miss-
ing data were handled by using the full information
maximum likelihood estimator [43, 44]. Participants with
missing data on all four time points were automatically
excluded from the analyses (5 adolescents, 11 parents).
A prerequisite to use this estimator is that missing
values of depressive symptoms are missing at random.
Little’s MCAR test showed that completely missing at
random and, therefore, also missing at random is sup-
ported (χ2 (41) = 47.46; p = 0.226).
To control for possible non-independence of the data
because of nesting participants within schools, the pro-
cedure COMPLEX with the robust maximum likelihood
estimator (MLR) was used. With this procedure, we got
unbiased standard errors of the parameter estimates.
Model fit indices were chi-square (df), the root mean
square of approximation (RMSEA; values < 0.08 means
acceptable fit) [45], and the Comparative Fit Index (CFI;
values > 0.90 means acceptable fit) [46]. Although these
global fit indices are less suited for small sample sizes
(N < 200) [47, 48], Coffman and Millsap found that des-
pite a poor global fit [49], a linear growth model may
provide a good approximation of the actual growth
curve. Therefore, in the first step, we examined the ad-
equacy of a linear model in comparison to a quadratic
model for adolescent ratings of depressive symptoms. A
linear model for both groups showed a fit of χ2 (10) =
24.13, p = 0.007, RMSEA = 0.151, CFI = 0.907. The fit
was acceptable according to the CFI-value and less ac-
ceptable according to the RMSEA value. A quadratic
model for both groups showed a fit of χ2 (2) = 0.46, p =
0.793, RMSEA = 0.000, CFI = 1.000. The fit of this model
was excellent, but the question arose whether for this
small sample of N = 130, a quadratic model was overfit-
ting the data [50]. Therefore, we examined how well the
estimated depressive symptoms scores at T1, T2, T3,
and T4 (according to a linear or a quadratic regression
model), correlated with the original scores on depressive
symptoms. For the linear model, the correlations were
0.86, 0.86, 0.85, and 0.97, and for the quadratic model,
the correlations were 0.98, 0.78, 0.98, and − 0.01. At T4,
the correlation between the original scores and the esti-
mated scores was zero, and this was an indication that a
quadratic model is overfitting the data. For this reason, a
linear model was chosen for adolescent-rated depressive
symptoms as most adequate for our purposes, with
intercept (i; initial estimated level of depressive symp-
toms) and slope (s; estimated degree of change of de-
pressive symptoms over time) as latent growth
parameters.
For parent-rated depressive symptoms, the fit of the
linear model was χ2 (10) = 24.60, p = 0.006, RMSEA =
0.157, CFI = 0.913. The fit was acceptable according to
the CFI-value and less acceptable according to the
RMSEA value. The fit for the quadratic model was χ2
(10) = 0.42, p = 0.810, RMSEA = 0.000, CFI = 1.000. Des-
pite this excellent fit, we found that for the linear model,
the correlations between original scores and estimated
scores were 0.90, 0.96, 0.86, and 0.97, and for the quad-
ratic model, the correlations were .98, .86, .98, and −.09,
indicating that a quadratic model was overfitting the
data. This supported the choice for a linear growth
model. To test differences in i and s between the experi-
mental and control condition, we used the χ2 difference
test and compared the χ2 value of the unconstrained
growth model with the χ2 value of the growth model,
where the i was constrained to be equal in both condi-
tions. A significant increase of the χ2 value from baseline
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to i-constrained model indicates a significant difference
of the mean intercept. In the same way, the χ2 value of
the i-constrained model was compared with the χ2 value
of the model, where both i and s were constrained to be
equal. A significant difference in χ2 value between both
models indicates a significant difference in mean slope.
As a result of using the MLR estimator, the χ2 values of
the models were divided by a scaling correction to get a
better approximate of the χ2 values. However, the differ-
ence between these two corrected χ2 values is not χ2 dis-
tributed. Therefore, the χ2 values of the models were
first rescaled to uncorrected χ2 values before calculating
the difference between the two χ2 values [51]. Effect sizes
for treatment efficacy were calculated by the difference
between the estimated means of the intervention and
control condition at the end of the study (determined
from the coefficient for the slope differences and length
of study) divided by the baseline pooled standard devi-
ation [52].
Additional analyses
We have performed additional analyses to examine indi-
vidual change over time of depressive symptoms. We
calculated the Reliable Change Index (RCI) for each par-
ticipant by dividing the pretest (T1) to follow-up (T4)
score difference by the standard error of this difference.
Adolescents with RCI scores above 1.96 were classified
as significantly improved, adolescents with RCI scores
between − 1.96 and 1.96 were classified as unchanged,
and adolescents with RCI scores below − 1.96 were clas-
sified as significantly worsened [53]. We used Fisher’s
exact test, followed by post hoc tests including Bonfer-
roni correction (to correct for capitalization on chance),
to test whether and how the classification of the inter-
vention group differed from those of the control group.
Furthermore, remission status of the participants that
meet the criteria of a depressive disorder at baseline
were calculated at the 6-month follow-ups, and the bin-
ary logistic regression analyses (with remission status as
dependent variable and condition as predictor) were
used to compare remission status between the experi-
mental and control condition.
Results
Descriptives
In total, 5222 adolescents were screened on depressive
symptoms. Of the 469 adolescents that emerged from
the screening, 130 participated in the study and were in-
cluded in the analyses. Participation rates were good
(T1 = 88.5%; T2 = 71.5%; T3 = 80.0%; T4 = 80.0%), with a
lower percentage at T2, probably due to the start of the
summer holiday. Table 1 shows descriptive statistics and
test results of a comparison between experimental and
control condition for depressive symptoms (adolescent
and parent rated) at all time points. No significant differ-
ences were found in adolescent-rated depressive symp-
toms between both conditions at T0, T1, T2, and T3. At
T4, adolescents in the experimental condition reported
significantly fewer depressive symptoms than adoles-
cents in the control condition. Parent-rated depressive
symptoms differed significantly between both conditions
at all time points, with higher means in the experimental
condition.
Latent growth curve modeling
In the analysis section, it is concluded that a linear
growth model for depressive symptoms is most appro-
priate for adolescent and parent ratings. Therefore, we
examined both linear growth models in which time was
coded in months (0, 3, 6, and 12months). For adolescent
ratings, the estimated growth parameters in this model
were: i = 15.54 and s = − 0.40 (p = < 0.001) in the inter-
vention condition and i = 14.95 and s = − 0.16 (p = <
0.001) in the control condition. Figure 2 shows this
Table 1 Means, standard deviations, and z values for differences on adolescent-rated (CDI-2:C) and parent-rated depressive
symptoms (CDI-2:P) between the intervention and control condition
Intervention condition (N = 66) Control condition (N = 64)
Adolescent-rated M SD M SD z value p
CDI-2:C T0 18.66 4.21 18.42 4.54 .41 .679
CDI-2:C T1 16.18 4.92 15.68 7.08 .45 .655
CDI-2:C T2 13.32 7.07 14.71 9.06 − .80 .423
CDI-2:C T3 12.10 6.85 13.72 8.72 − .98 .326
CDI-2:C T4 10.78 7.05 13.32 7.50 − 1.98 .048
Parent-rated (N = 60) (N = 59)
CDI-2:P T1 20.14 5.54 16.78 5.86 2.57 .010
CDI-2:P T2 18.66 6.00 15.09 6.36 2.96 .003
CDI-2:P T3 17.42 6.27 14.41 6.21 2.94 .003
CDI-2:P T4 16.59 6.34 14.07 6.53 2.10 .035
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model. The second step was to test our hypothesis that
the intervention condition would show a greater de-
crease in depressive symptoms than the control condi-
tion. First, we tested whether the intercept was different
between both conditions. The χ2 difference test was not
significant, with Δχ2(1) = 0.07 and p = 0.791, indicating
that the mean starting level of depressive symptoms was
not significantly different between both conditions. Next,
we tested whether the slope was different between both
conditions. The χ2 difference test showed a significant
effect, with Δχ2(1) = 4.35 and p = 0.037, indicating that
the decrease in depressive symptoms was larger in the
intervention condition compared to the control
condition. The effect is 0.47, indicating an almost
medium effect size.
For parent ratings, the parameters were i = 19.72 and
s = − 0.28 (p = < 0.001) in the intervention condition, and
i = 16.14 and s = − 0.19 (p = 0.018) in the control condi-
tion. Figure 3 shows this model. The intercept appeared
to be significant between both conditions, and the χ2 dif-
ference test showed a significant effect for the intercept
with Δχ2(1) = 10.76 and p = 0.001. The mean starting
level of depressive symptoms in the intervention condi-
tion is significantly higher than in the control condition.
There was no significant difference in decrease of
parent-rated depressive symptoms between both
Fig. 2 Mean scores of adolescent-reported depressive symptoms over time in the experimental and control condition
Fig. 3 Mean scores of parent-rated depressive symptoms over time in the experimental and control condition
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conditions (Δχ2(1) = 1.75; p = 0.186). The effect size is
0.19, indicating a very small effect size.
Individual change over time
Between the baseline and 12-month follow-up, 38.3% of
the adolescents in the intervention condition improved,
compared to 12.5% in the control condition. The per-
centage of adolescents that worsened was 2.1% in the ex-
perimental condition, compared to 8.3% in the control
condition. The percentage of adolescents that remained
unchanged was 59.6% in the intervention condition and
79.2% in the control condition. Fisher’s exact test
showed a p value of 0.007, indicating that the control
condition differed from the intervention condition. Post
hoc test including Bonferroni correction showed that in
the intervention condition, the percentage of participants
that did not change was significantly lower, and the per-
centage of participants that improved was significantly
higher than in the control condition.
Remission status
Furthermore, we calculated the remission status of par-
ticipants that met the criteria of a depressive disorder in
both conditions. Only participants for whom pretest and
the 6-month follow-up measure of the ADIS-C were
available were included in the analysis. A total of 105
participants met this criterion. At pre-test, 7 participants
(10.8%) in the intervention condition and 12 participants
(19.7%) in the control condition fulfilled the diagnosis of
a depressive disorder. At the 6-month follow-up, 3 par-
ticipants (5.5%) in the intervention condition and 4
(7.7%) in the control condition fulfilled the diagnosis of
a depressive disorder. Binary logistic regression analyses
revealed that remission status did not differ between
conditions (OR = 0.83, p = 0.906).
Discussion
The aim of the present study was to test the effective-
ness of OVK 2.0 in the prevention of depression for ado-
lescents with elevated depressive symptoms when
implemented in school communities. Findings from
LGCM show that the decrease in self-reported depres-
sive symptoms was significant in both conditions, from
the baseline to 12 months after the interventions, and
that the decrease in depressive symptoms was signifi-
cantly larger in the experimental condition with 42.6%
of the adolescents who improved, than in the control
condition with 16.2% of the adolescents who improved.
This indicates that a CBT prevention program is effect-
ive in reducing elevated depressive symptoms in adoles-
cents when implemented in school communities.
Based on the findings, we recommend the implemen-
tation of screening and prevention in schools according
the basics of this study design, which is screening on
depressive symptoms and suicidal ideation and providing
indicated prevention. Although psycho-education could
be a low-cost and easier way for offering prevention, the
findings indicate that CBT-based prevention might en-
sure more sustainable outcomes. Although this study did
not examine the advantages or benefits from the inte-
grated care approach that formed the base of this study,
we experienced that there are a number of foreseen as
well unforeseen profits. In addition to the improved col-
laboration between schools and care providers, we were
able to identify and refer adolescents high at risk for sui-
cidality. Important as well, we experienced that, in both
conditions, the confidence of schools and care profes-
sionals regarding this topic increased over the course of
the study and that adolescents felt more comfortable to
display their worries or feelings within the school set-
ting. Moreover, schools became activated in their role in
prevention. Where in the first year of this project
schools and care givers were hesitant, in the second year,
they took initiative by planning for the next years and
suggesting improvements. Also, schools initiated collab-
oration on other mental healthcare themes, such as self-
harm. This way, such collaboration might form a stable
infrastructure in which new developments can be
adapted to improve prevention.
The positive findings regarding the effects of OVK 2.0
are promising in many ways. First, the findings are in
line with Wijnhoven and colleagues [33], who found
similar effects for OVK 2.0 in a sample of high-risk ado-
lescent girls. This is important because we are often un-
aware of the relative effectiveness or circumstances that
modify the effectiveness; therefore, it is likely that effects
might not sustain when transferring into practice. This
study showed that OVK 2.0, when part of implemented
depression prevention, was also effective in reducing de-
pressive symptoms in a mixed sample with boys and girls
and when provided by different trainers. Second, although
meta-analyses show that indicated prevention seem to be
effective in the short term only [10, 15], this study showed
that the effect remained at the 12-month follow-up. Lastly,
to our knowledge, this is the first study that examined in-
dicated depression prevention in adolescents when imple-
mented in the school community; therefore, the findings
give hope for future implementation.
Despite the significant decrease of self-reported de-
pressive symptoms in the OVK 2.0 condition, there was
no significant difference in the decrease of parent-rated
depressive symptoms. Also, there was no significant dif-
ference between conditions in future incidence of de-
pressive episodes. Although the study is underpowered
to detect differences in depression onset, it is encour-
aging that, given the sharp increase in depression rates
during adolescence, depressive symptoms actually de-
creased during the study.
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Furthermore, a discrepancy between parents and ado-
lescents in the report of depressive symptoms is fre-
quently observed, with parents over-reporting in a
general population and underreporting in a clinical
population [30, 54]. Parents seem to be more aware of
symptoms when they become severe, possibly because
symptoms then become visible. This could also explain
the higher starting level of parent-reported depressive
symptoms in the intervention condition, as compared to
the control condition. By allocation to the intervention
condition, parents might be more aware of symptoms
and a possible change due to the active character of the
intervention than in the relatively passive control condi-
tion. Also, nonresponses and the different reasons for
this nonresponse might have caused the observed differ-
ence. For example, high parent-rated scores might be
missing due to disappointment of parents that their
child did not made it to the intervention condition.
Nevertheless, future research should continue to include
both informants as a study of Cohen and colleagues [55]
showed that adolescent-reported symptoms are the best
predictors for concurrent depressive episodes; however,
to predict future episodes, both adolescent and parent
reports were necessary. Parents seem to be better in
identifying behavioral signs that are important precur-
sors of a depression.
Strengths and limitations
This study has some important strengths. First, we im-
plemented the evaluated preventive interventions in
school communities, which allowed us to examine the
effects of OVK 2.0 under real-life circumstances. Second,
we used adolescent-rated and parent-rated depressive
symptoms. Moreover, we used a clinical interview to de-
termine the effects of depression prevention on actual
prevention of diagnoses of depression. Third, the study
design allowed us to examine the effectiveness of OVK
2.0 beyond an active control condition. Finally, the
follow-up measurements allowed us to examine the
long-term effectiveness of the intervention.
Despite the robust RCT design, some limitations must
be noted. Randomization was carried out at the school
level, which limits the random allocation of participants.
Also, in the control condition, we did not measure if ad-
olescents actually read the psycho-education and
whether they found this information helpful, which
limits the fidelity of this intervention. Furthermore, only
27% of the adolescents that were approached to partici-
pate in this study agreed to participate. This raises ques-
tions about a bias in selection of the participant group.
For example, we noticed that parents in this age group
had an important voice in whether to participate. A rela-
tively large group of adolescents were initially not very
motivated for participation, and it was up to their
parent(s) if participation was refused or reconsidered.
When depressive symptoms were not recognized in
everyday life, it was more likely that they refused to par-
ticipate (see also Fig. 1). Therefore, it might be that par-
ticipated adolescents had more concerned parents or
parents that endorsed the importance of prevention.
This parent’s concern might also be displayed by the
higher parent-rated depressive symptoms, as compared
to adolescent-rated symptoms. Although the sample size
was too small to rule out the effect of selectivity, future
implementation studies should search for strategies to
maximize enrollment.
Clinical implications
Integrating depression prevention in (school) communi-
ties is a new step forward that brings new questions and
challenges. As discussed in the limitations, motivating
adolescents and parents for participation is one of those
challenges. In order to improve enrollment, it is crucial
to examine how we can improve the acceptability of pre-
vention programs which might lower the threshold to
join these programs. We experienced that the most im-
portant reasons to decline participation were the lack of
motivation and the lack of understanding of utility and
necessity of adolescents or parents. It is important to
examine the best approach to increase the motivation
and the sense of urgency, for example, by decreasing the
stigma of depression among adolescents. Universal men-
tal health programs could create more awareness of
mental health and promote help-seeking behavior in ad-
olescents [56], especially when this is integrated into the
school curriculum.
In addition to the adolescents, it also seems important
to create awareness in the adolescent’s environment, for
example, by introducing parent information sessions in
schools regarding this theme. Also, teachers and men-
tors, who are often in contact with both adolescents and
parents, should be able to recognize depressive symp-
toms and support in the participation in prevention pro-
grams or the process of help-seeking. The gatekeeper
training, for example, can be used for this purpose. Al-
though the main goal of this training is to learn how to
respond to suicidality, it proved to be helpful in referring
adolescents to appropriate mental health services, espe-
cially when given in school-based settings [57, 58].
Moreover, the training improves knowledge of suicidality
and confidence to conduct a dialog on suicidal thoughts
[57]. Given the strong association between the presence
of suicidality and depressive symptoms, as well as the
screening on suicidality as a prevention strategy, the
gatekeeper training might be a sufficient tool to engage
teachers and mentors in depression and suicide
prevention.
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Future research
This study showed an overall decrease in depressive
symptoms for adolescents receiving the intervention.
However, we have also shown that not all individuals
benefited from the prevention program. The next step in
research should be to gain more insight in for whom this
strategy is effective, often mentioned as precision pre-
vention. Earlier research, specifically longitudinal studies,
identified four classes of adolescents, with each class
characterized by a pattern of change of depressive symp-
toms: (1) low stable or no symptoms, (2) intermediate
symptoms that decrease over time, (3) intermediate
symptoms that increase over time, and (4) chronic or
persistent high level of symptoms [59, 60]. The know-
ledge of these development patterns of depressive symp-
toms should be used to explore the effect of the
intervention and to study if we could predict whether in-
dividuals respond to prevention programs. Another sug-
gestion is to study whether certain risk factors or risk
patterns predict the responsiveness of individuals to a
prevention program. We expect that the chronic or per-
sistent group includes adolescents at risk who are almost
resistant for prevention programs due to a combination
of risk factors (e.g., parental psychopathology, obesity, or
traumatic childhood experiences). Future research
should focus on the identification of these risk patterns,
as this can be used to advance the screening and preven-
tion process, for example, by combining parent and ado-
lescent depression treatment or timely upscaling of
mental healthcare. These suggestions should result in
more insights into for whom the intervention will be ef-
fective or not and is necessary to take precision preven-
tion to the next level.
Conclusions
In conclusion, this study showed that a CBT program, as
indicated depression prevention, is effective in reducing
depressive symptoms when implemented in school com-
munities. Given the high rates of adolescents that suffer
from depressive feelings worldwide, implementation of in-
dicated prevention programs, screenings, and subsequent
referrals of suicidality are priorities. Schools, care givers,
politicians, communities, and researchers should cooper-
ate in the sustainable implementation of depression pre-
vention. Bridging the gap between science and practice is
challenging; however, with the opportunity to improve
prevention work, the challenge is worth pursuing.
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